• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Earlier Vacuum Therapy Improves Erectile Function in Nerve-Injured Rats

by
November 10, 2026
in Biology
Reading Time: 4 mins read
0
Earlier Vacuum Therapy Improves Erectile Function in Nerve-Injured Rats

Earlier Vacuum Therapy Improves Erectile Function in Nerve-Injured Rats

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Modified vacuum erection device therapy administered with an advanced therapeutic window attenuated smooth muscle phenotypic remodeling and improved erectile function in rats subjected to bilateral cavernous nerve injury, according to research published in Cell Biology and Toxicology.

Bilateral cavernous nerve injury frequently causes erectile dysfunction as a complication following radical prostatectomy. While vacuum erection device therapy has been used in rehabilitative protocols to counteract cavernous ischemia and hypoxia, the precise timing required to optimize therapeutic outcomes has remained incompletely defined, and the cellular mechanisms linking tissue hypoxia to phenotypic remodeling in corpus cavernosum smooth muscle cells have been unclear.

To evaluate whether adjusting the intervention schedule provides therapeutic advantages, researchers developed an animal model involving bilateral cavernous nerve injury alongside in vitro cellular models. The team compared the modified vacuum erection device protocol against conventional therapy, holding the vacuum parameters and treatment frequency identical while advancing the initiation window of the intervention.

In vivo assessments confirmed that the modified therapy demonstrated superior efficacy over conventional protocols. Rats receiving the earlier intervention exhibited reduced phenotypic remodeling within the cavernous smooth muscle tissue and achieved improved erectile function measurements following nerve injury.

To determine the molecular mechanisms governing these changes, the investigators established a primary corpus cavernosum smooth muscle cell hypoxia model and conducted phenotypic detection alongside CUT&Tag-qPCR assays. In vitro experiments revealed that hypoxia-inducible factor-1α, a molecule critical for cellular adaptation to hypoxic conditions, plays a central role in driving smooth muscle phenotypic remodeling, where its overexpression intensified remodeling and its knockdown mitigated the process.

Mechanistic assays demonstrated that hypoxia-inducible factor-1α directly activates the transcription of somatic cytochrome c. Interventions utilizing targeted mitochondrial antioxidants or experimental knockdown of cytochrome c restored mitochondrial function and attenuated the phenotypic remodeling of smooth muscle cells, indicating that the modified therapy acts by suppressing the hypoxia-inducible factor-1α and cytochrome c pathway to alleviate mitochondrial dysfunction. The authors concluded that these findings offer a preclinical mechanistic foundation for investigating earlier device intervention in post-nerve injury erectile dysfunction, while noting that the observations remain restricted to animal and cell models.

In establishing the experimental framework, the researchers focused on the pathophysiological sequelae of bilateral cavernous nerve injury, which frequently manifests as erectile dysfunction following radical prostatectomy. To directly evaluate how altering the intervention schedule influences tissue recovery, the investigators maintained rigorous consistency across physical device settings. Specifically, the modified vacuum erection device protocol utilized the exact same vacuum parameters and application frequency as conventional therapy, isolating the advanced therapeutic window as the sole variable under evaluation. By applying this early timing regimen in the bilateral cavernous nerve injury rat model, the study was designed to determine whether earlier mechanical intervention could mitigate cavernous ischemia and tissue hypoxia more effectively than traditional post-injury timelines.

To delineate the intracellular signaling cascades underlying cavernous tissue alterations, the study incorporated complementary in vitro assays utilizing a primary corpus cavernosum smooth muscle cell hypoxia model. Hypoxia-inducible factor-1α serves as a critical regulatory molecule mediating cellular adaptation to low-oxygen environments. In this cellular system, experimental modulation demonstrated a pivotal role for hypoxia-inducible factor-1α in driving smooth muscle phenotypic remodeling. Targeted overexpression of hypoxia-inducible factor-1α exacerbated phenotypic remodeling in hypoxic corpus cavernosum smooth muscle cells, whereas targeted knockdown attenuated the remodeling response. Furthermore, CUT&Tag-qPCR assays revealed the precise transcriptional mechanism, confirming that hypoxia-inducible factor-1α directly transcriptionally activates somatic cytochrome c within these cells.

The downstream consequences of this transcriptional activation centered on mitochondrial integrity within the smooth muscle cells. When researchers performed experimental knockdown of somatic cytochrome c, the intervention successfully restored mitochondrial function and attenuated the phenotypic remodeling induced by hypoxic exposure. Similarly, the administration of a targeted mitochondrial antioxidant intervention restored mitochondrial function and mitigated phenotypic remodeling in primary corpus cavernosum smooth muscle cells. Together, these cellular findings explain the biological process observed in vivo, demonstrating that the superior efficacy of modified vacuum erection device therapy in bilateral cavernous nerve injury rats relies on suppressing the hypoxia-inducible factor-1α and somatic cytochrome c axis to alleviate mitochondrial dysfunction.

The authors emphasized that these findings provide a preclinical mechanistic basis for further exploration of advanced device initiation rather than immediate clinical recommendations. Because the experimental evidence derives exclusively from bilateral cavernous nerve injury rat models and primary corpus cavernosum smooth muscle cell hypoxia cultures, direct therapeutic equivalence and functional recovery in human surgical patients remain to be established. Furthermore, while the data demonstrate that modified timing attenuates phenotypic remodeling and improves post-injury erectile function compared with conventional therapy, the optimal timing of vacuum erection device initiation across diverse post-prostatectomy scenarios remains incompletely defined, underscoring the necessity of further preclinical and translational investigation.

Subject of Research: Modified vacuum erection device therapy for post-nerve injury erectile dysfunction in rats

Article Title: Modified vacuum erection device therapy attenuates smooth muscle phenotypic remodeling via the HIF-1α/CYCS/mitochondrial axis to improve erectile function in rats with bilateral cavernous nerve injury

Article References: Luo, J.-Q., Liao, Z.-Q., Mao, Z.-H., Luo, C.-Y., Lu, B.-X., He, H.-Y., Xiang, Y.-R., He, S.-H., Wei, A.-Y., Zhang, H.-B., Wei, B., & Zhang, Y. (2026). Modified vacuum erection device therapy attenuates smooth muscle phenotypic remodeling via the HIF-1α/CYCS/mitochondrial axis to improve erectile function in rats with bilateral cavernous nerve injury. Cell Biology and Toxicology. https://doi.org/10.1007/s10565-026-10288-8

Image Credits: AI Generated

DOI: 10.1007/s10565-026-10288-8

Keywords: Erectile dysfunction, Vacuum erection device, Cavernous nerve injury, Corpus cavernosum, HIF-1alpha, Mitochondrial dysfunction, Smooth muscle remodeling, Preclinical urology, Modified, vacuum, erection, device

News Source: Drew Townsend. (November 10, 2026). Earlier Vacuum Therapy Improves Erectile Function in Nerve-Injured Rats. Scienmag.

Tags: cavernous nerve injurycorpus cavernosumdeviceerectile dysfunctionerectionHIF-1alphaMitochondrial dysfunctionmodifiedPreclinical urologySmooth muscle remodelingVacuumVacuum erection device
Share12Tweet7Share2ShareShareShare1

Related Posts

Gambian Oyster Harvesters Report Declining Abundance as Commercial Pressures Mount

Gambian Oyster Harvesters Report Declining Abundance as Commercial Pressures Mount

November 18, 2026
Intergenerational Erosion of Tacit Storm Prediction Among Karachi Fishers

Intergenerational Erosion of Tacit Storm Prediction Among Karachi Fishers

November 18, 2026

Mammary Stem and Progenitor Cells Show Distinct Lineage Dynamics Across Development

November 18, 2026

GABA Treatment Associated With Modulated Drought Responses in Contrasting Flax Varieties

November 18, 2026

POPULAR NEWS

  • Electroacupuncture Mobilizes Unique CD34-Positive Stem-Like Cells in Healthy Dogs

    Electroacupuncture Mobilizes Unique CD34-Positive Stem-Like Cells in Healthy Dogs

    29 shares
    Share 12 Tweet 7
  • Specialists Outline Cervical Cancer Screening Principles for Resource-Limited Settings

    29 shares
    Share 12 Tweet 7
  • Modified Halpern Proximal Algorithm Solves Multi-Structured Problems in Curved Hadamard Spaces

    29 shares
    Share 12 Tweet 7
  • Machine Learning Outperforms Pharmacokinetic Models Predicting Initial Vancomycin Concentrations in Septic Patients

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Pesticide Handlers in Tanzanian Agriculture Show Significant Acetylcholinesterase Enzyme Suppression

Rare Unilateral Neuroretinitis Linked to Dengue Infection in Returning Traveller

Coated Intramedullary Nails Yield Low Infection Rates in High-Risk Long-Bone Fractures

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.